Related Experiment Video
Updated: Aug 16, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Morphological manifestations of heart remodeling in anthracycline-induced dilated cardiomyopathy
E L Lushnikova1, M G Klinnikova, O P Molodykh
1Department of Cell Biology and Morphology, Institute of Regional Pathology and Pathomorphology, Siberian Division, Russian Academy of Medical Sciences, Novosibirsk. pathol@soramn.ru
Abstract:
The morphogenesis of anthracycline-induced dilated cardiomyopathy was studied after single sublethal dose of doxorubicin. Cardiomyocyte depopulation (up to 27%) and decrease in their regeneratory plastic reactions were the main mechanisms of cardiac failure development after anthracycline (doxorubicin) treatment, determining the type of heart remodeling by the dilatation variant. Cardiomyocyte elimination and atrophy during the development of anthracycline-induced regeneratory plastic cardiac insufficiency were paralleled by hypertrophy of remaining cardiomyocytes and diffuse and small focal sclerosis of the myocardium, which could be regarded as a correlated compensatory reaction of the connective tissue to the decrease in the number of muscle fibers.
Insights
Doxorubicin treatment causes dilated cardiomyopathy by reducing heart muscle cell numbers and regeneration. Remaining cells enlarge, and connective tissue stiffens as a compensatory response to heart failure.
Area of Science:
- Cardiology
- Toxicology
- Pathology
Background:
- Anthracyclines, like doxorubicin, are potent chemotherapy agents.
- Cardiotoxicity is a significant dose-limiting side effect of anthracycline therapy.
- Dilated cardiomyopathy is a severe form of heart muscle disease.
Purpose of the Study:
- To investigate the mechanisms of anthracycline-induced dilated cardiomyopathy.
- To understand the cardiac remodeling processes following doxorubicin exposure.
- To elucidate the role of cardiomyocyte loss and regeneration in heart failure.
Main Methods:
- Administration of a single sublethal dose of doxorubicin to a study model.
- Analysis of cardiomyocyte depopulation and regenerative capacity.
- Assessment of myocardial hypertrophy and fibrosis.
Main Results:
- Doxorubicin treatment led to significant cardiomyocyte depopulation (up to 27%).
- Reduced regenerative plastic reactions of cardiomyocytes were observed.
- Hypertrophy of surviving cardiomyocytes and myocardial sclerosis occurred as compensatory responses.
Conclusions:
- Cardiomyocyte elimination and impaired regeneration are key drivers of doxorubicin-induced heart failure.
- Heart remodeling is characterized by dilatation and fibrosis.
- Connective tissue sclerosis represents a compensatory reaction to muscle fiber loss.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care

